DK0710479T3 - Anvendelse af en serotoninagonist sammen med en tachykininreceptorantagonist til fremstilling af et medikament til behandli - Google Patents

Anvendelse af en serotoninagonist sammen med en tachykininreceptorantagonist til fremstilling af et medikament til behandli

Info

Publication number
DK0710479T3
DK0710479T3 DK95307000T DK95307000T DK0710479T3 DK 0710479 T3 DK0710479 T3 DK 0710479T3 DK 95307000 T DK95307000 T DK 95307000T DK 95307000 T DK95307000 T DK 95307000T DK 0710479 T3 DK0710479 T3 DK 0710479T3
Authority
DK
Denmark
Prior art keywords
treatment
receptor antagonist
medicament
prepare
tachykinin receptor
Prior art date
Application number
DK95307000T
Other languages
English (en)
Inventor
Marlene Lois Cohen
Kirk Willis Johnson
Lee Alan Phebus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0710479T3 publication Critical patent/DK0710479T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95307000T 1994-10-05 1995-10-03 Anvendelse af en serotoninagonist sammen med en tachykininreceptorantagonist til fremstilling af et medikament til behandli DK0710479T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/318,391 US5744482A (en) 1994-10-05 1994-10-05 Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine

Publications (1)

Publication Number Publication Date
DK0710479T3 true DK0710479T3 (da) 1999-08-30

Family

ID=23237987

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95307000T DK0710479T3 (da) 1994-10-05 1995-10-03 Anvendelse af en serotoninagonist sammen med en tachykininreceptorantagonist til fremstilling af et medikament til behandli

Country Status (12)

Country Link
US (1) US5744482A (da)
EP (1) EP0710479B1 (da)
AT (1) ATE175347T1 (da)
AU (1) AU4130196A (da)
DE (1) DE69507112T2 (da)
DK (1) DK0710479T3 (da)
ES (1) ES2125567T3 (da)
GR (1) GR3029666T3 (da)
IL (1) IL115451A0 (da)
SI (1) SI0710479T1 (da)
WO (1) WO1996011000A1 (da)
ZA (1) ZA958173B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US6492332B1 (en) * 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
AU4467396A (en) 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
RU2180852C2 (ru) * 1994-12-12 2002-03-27 Омерос Медикл Системс, Инк. Ингибирующий раствор и способ подавления боли, воспаления или спазма
US20040127884A1 (en) * 1994-12-12 2004-07-01 Omeros Corporation Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
AU5966196A (en) * 1995-06-08 1997-01-09 Eli Lilly And Company Methods of treating cold and allergic rhinitis
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
AU4074897A (en) * 1996-09-18 1998-04-14 Eli Lilly And Company A method for the prevention of migraine
GB9620777D0 (en) * 1996-10-07 1996-11-20 Merck Sharp & Dohme Therapeutic use
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
DE19917347A1 (de) * 1999-04-16 2000-11-09 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe
CA2324116A1 (en) * 1999-10-25 2001-04-25 Susan Beth Sobolov-Jaynes Nk-1 receptor antagonists and eletriptan for the treatment of migraine
AUPQ514600A0 (en) 2000-01-18 2000-02-10 James Cook University Brain injury treatment
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
US7998986B2 (en) 2001-12-21 2011-08-16 Exelixis Patent Company Llc Modulators of LXR
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
US20050282879A1 (en) * 2004-06-17 2005-12-22 Foad Salehani Methods and composition for treatment of migraine and symptoms thereof
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
AU2008297926A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection

Also Published As

Publication number Publication date
ES2125567T3 (es) 1999-03-01
SI0710479T1 (en) 1999-06-30
IL115451A0 (en) 1995-09-28
EP0710479B1 (en) 1999-01-07
US5744482A (en) 1998-04-28
DE69507112D1 (de) 1999-02-18
EP0710479A1 (en) 1996-05-08
WO1996011000A1 (en) 1996-04-18
AU4130196A (en) 1996-05-02
DE69507112T2 (de) 1999-06-10
ATE175347T1 (de) 1999-01-15
GR3029666T3 (en) 1999-06-30
ZA958173B (en) 1997-04-01

Similar Documents

Publication Publication Date Title
GR3029666T3 (en) Use of a serotonin agonist in combination with a tachykinin receptor antagonist for the manufacture of a medicament for the treatment or prevention of migraine
DE69734006D1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda-antagonist
NO2013017I2 (no) (a)dekstrometorfan eller et farmasøytisk akseptabelt salt derav, for eksempel dekstrometorfanhydrobromid og (b) quinidin eller etfarmasøytisk akseptabelt salt derav, for eksempel quinidinsulfat
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
BR0106462A (pt) Composições farmacêuticas para distúrbios do snc e outros distúrbios
BR0200283A (pt) Composições farmacêuticas para o tratamento de distúrbios do snc e de outros distúrbios
DK0411668T4 (da) Central-chlolecystokinin-antagonister til behandling af psykiske forstyrrelser
BR9106977A (pt) Metodo para suprimir destruicao autoimune de celuias beta pancreaticas,formulacao farmaceutica,metodo de profilaxia,metodo para prevenir o surgimento de diabetes tipo 1 e metodo para tratar um mamifero
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
BR9709915A (pt) Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto
US20040214849A1 (en) Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
MX9700030A (es) Administracion de pirenzipina, matilescopolamina y otros antagonistas del receptor mascurinico para el tratamiento de transtornos del metabolismo de lipidos.
AR017723A1 (es) Uso de 4-(1-etil-propoxi)3,6-dimetil-2-(2,4,6-trimetil-fenoxi)piridina o (3,6-dimetil-2-(2,4,6-trimetil-fenoxi)-piridin-4-il)-(1-etil-propil)-amina, unprofarmaco de las mismas o una sal farmaceuticamente aceptable de las mismas o de dicho profarmaco para la preparacion de un medicamento para el trat
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
MXPA01008993A (es) Tratamiento de combinacion para depresion y ansiedad.
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
TR200200913T2 (tr) Bir NK1 reseptörü antagonistini ve bir gaba yapısal analoğunun sinerjik kombinasyonları.
DE60014429D1 (de) Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DK1156795T3 (da) Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens